Deal to create multifunctional molecules

Printer-friendly version Printer Friendly Version
Email Story Send This Story

July 2010
The HallStar Company and SurfaTech Corporation have formed a cooperative development agreement to create and market new multifunctional molecules for personal care formulations.

SurfaTech Corporation is associated with Siltech, LLC, which was founded by Tony O’Lenick. Initial research will look at ways to derivatise HallStar’s patented photostability technologies to create unique ingredients that improve both the utility and feel of sunscreen and sun protection product formulations. “This is a major step forward for both of our companies,” said John Paro, chairman, president, and CEO of HallStar. “I predict that we are going to see some cutting-edge technologies emerge from this agreement, which will really benefit formulators, and ultimately, consumers.” Craig Bonda, of HallStar, and Tony O’Lenick will lead the development team. “Our goal is to provide an excellent user experience in a wide range of personal care formulations – from sun care to daily wear,” said Kevin O’Lenick, president of SurfaTech. “This agreement gives us the chance to deliver outstanding cosmetic elegance utilising HallStar’s photostabilising technologies.” 

 


Printer-friendly version Printer Friendly Version
Email Story Send This Story
Supplier Search
Article Search
Formulations Search

PRODUCT ARTICLE

A true petrolatum alternative
Until antibiotics conquered the world, the only possible method for curing gangrene was maggot therapy, except for amputation of the extremities. Maggots were applied to the wound and would eat the necrotic tissue, including the organisms that were responsible for that.

TECHNICAL ARTICLE

Skin defences boosted by grapefruit extract
Humans are constantly exposed to harmful foreign chemicals and materials from exogenous and endogenous sources. As a result, defence mechanisms have evolved to protect against toxin overload.1 Cells are under constant threat from metabolic waste products and xenobiotics. The formation of phase I and phase II metabolism mobilises and excretes these mainly lipophilic toxins.